Emily Carter Anti-Müllerian hormone (AMH) testing has become one of the more frequently discussed fertility assessments for women in their mid-thirties and beyond. For women thinking about their reproductive timeline — whether actively trying to conceive or simply curious about their fertility — AMH results can feel both illuminating and anxiety-inducing. Understanding what AMH actually measures, what … Ler mais
One of the most significant aspects of prenatal care that distinguishes pregnancy after 35 is the recommendation for—and discussion about—genetic screening and diagnostic testing. For many women, these conversations begin even before pregnancy or shortly after a positive test, and navigating the options, their purposes, and their limitations can feel overwhelming without some background context. … Ler mais
Perimenopause—the transitional phase leading up to menopause—is often discussed as something that begins in the late 40s, but research suggests many women begin experiencing subtle hormonal shifts in their late 30s and early 40s. This creates an interesting overlap: women who are still hoping to conceive may be entering the early stages of a reproductive … Ler mais
Anti-Müllerian hormone, more commonly known as AMH, has become one of the most widely discussed fertility markers in recent years. A single blood test, available directly to consumers through various labs and often ordered during fertility evaluations, seems to promise an answer to a question many women deeply want to know: how much fertility time … Ler mais
Estrogen is one of the most studied hormones in women’s health, and its influence extends far beyond the reproductive system. Research has increasingly documented estrogen’s interactions with brain function, temperature regulation, mood, and—relevantly for many women in midlife—sleep. Understanding these connections can provide useful context for women who notice sleep changes in their late 30s, … Ler mais
Ovarian reserve testing has become a significant part of the fertility conversation for many women over 35. Whether you’ve encountered a low AMH number in a fertility workup, had a healthcare provider mention “diminished ovarian reserve,” or are simply trying to understand what these tests measure before you pursue them, understanding what ovarian reserve actually … Ler mais
The thyroid gland plays a surprisingly central role in reproductive health, yet it’s often not part of the initial conversation when women begin thinking about fertility after 35. Research suggests that thyroid dysfunction—both overactive and underactive thyroid—is associated with various aspects of menstrual cycle regularity, ovulatory function, and pregnancy outcomes. Understanding this connection can help … Ler mais
Anxiety during pregnancy is more common than many women realize, and for those who are pregnant after 35, there are often additional layers of worry layered on top of the typical concerns of expecting a baby. The combination of age-related risk statistics, increased prenatal testing, and the cultural messaging around “geriatric pregnancy” can create an … Ler mais
Trying to conceive after 37 is something a growing number of women are navigating, and the experience often comes with a mix of hope, uncertainty, and a lot of conflicting information. Some of what’s commonly said about fertility after 37 is grounded in solid research; some of it is oversimplified or shaped by outdated data. … Ler mais
One of the conversations that comes up early in many pregnancies after 35 is prenatal genetic testing. The options have expanded considerably over the past decade, and for many women, navigating the different types of tests—what they look for, what their results mean, and how to make decisions that align with personal values—can feel overwhelming. … Ler mais